Rituximab-associated PRES in antibody-mediated kidney rejection: A case report

M Etemadifar, SA Alaei, E Saffari, M Salari - Transplant Immunology, 2023 - Elsevier
Abstract Posterior Reversible Encephalopathy Syndrome (PRES) is a rare neurological
disorder with a wide range of neurological symptoms. Different risk factors are known for …

A Young Patient with Microscopic Polyangiitis Requiring Hemodialysis with Complications of Repeated Episodes of Posterior Reversible Encephalopathy Syndrome …

S Asakawa, S Arai, M Kawagoe, C Ohata, W Ono… - Internal …, 2022 - jstage.jst.go.jp
A young woman with microscopic polyangiitis (MPA) requiring hemodialysis showed
repeated posterior reversible encephalopathy syndrome (PRES) with spatiotemporal …

[HTML][HTML] Posterior Reversible Encephalopathy Syndrome Secondary to R-CHOP Chemotherapy Regimen

S Jennane, EM Mahtat, M Ababou, H El Maaroufi… - Cureus, 2022 - ncbi.nlm.nih.gov
Chemotherapy-induced posterior reversible encephalopathy (PRES) syndrome is a rare
event. Its recurrence after reusing the incriminated molecules remains unpredictable. We …